Matt Doocey on new suicide prevention plan
health politics 44 minutes ago
The government has this morning released its second Suicide Prevention Action Plan. Minister for Mental Health Matt Doocey joins Kathryn to discuss what's in it, and how it will sit alongside work to improve Kiwis' access to mental health and addiction services.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
7 hours ago
- RNZ News
Allegations public money used by Whānau Ora for 'electioneering' to be investigated
Moana Pasifika allegedly received $770,000 a year from the Whānau Ora contract with Pasifika Medical Association. Photo: Andy Radka/ActionPress Te Puni Kōkiri (TPK) has launched an independent review into allegations of inappropriate use of public funding appropriated for Whānau Ora commissioning services. The independent review relates to allegations of funding misuse by two agencies, Te Pou Matakana Limited - otherwise known as the Whānau Ora Commissioning Agency - and Pasifika Futures Limited, and would focus on whether the agencies met their contractual obligations when using the public money. The review followed Māori Development Minister Tama Potaka seeking urgent advice on "electioneering concerns" relating to an advertisement encouraging Māori to sign-up to the Māori electoral roll paid for by Te Pou Matakana Limited released this week, and the revelation Super Rugby franchise Moana Pasifika had also received Whānau Ora funds . Dave Samuels, chief executive of Te Puni Kōkiri has called for the 'thorough review". Photo: TPK Te Puni Kōkiri chief executive and secretary for Māori development Dave Samuels said Te Puni Kōkiri had written to both organisations looking for an explanation. "It is in everyone's best interest that we find out what happened. We must safeguard taxpayers' money which is why I have commissioned a thorough review to get to the bottom of these serious allegations," Samuels said. The reviewer and terms of reference for the review were expected to be announced next week, however, Outcome Agreements signed with the two agencies and whether they met their contractual obligations would be in scope. Te Puni Kōkiri said after an open procurement process Whānau Ora had shifted to a new and transparent funding model with data-driven insights, which would make it easier to measure outcomes and ensure value for money. Commissioning contracts with Te Pou Matakana Limited and Pasifika Futures Limited end on Monday, and four new commissioning agencies begin Whānau Ora contracts the next day on 1 July. Te Pou Matakana Limited and Pasifika Futures Limited have been approached by RNZ for comment. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
7 hours ago
- RNZ News
Shortage of ADHD meds, loosening prescribing rules causing dad to ration son's supply
A dad is worried his son will run out of ADHD medication with changes on the way to who can prescribe the drugs. Photo: AFP / Thom Leach / Science Photo Library The father of a boy using ADHD medication is rationing his son's medication because of drug shortages and is worried things will get worse when new prescribing rules are introduced. From next year GPs and specialist nurses will be able to diagnose and prescribe medication for attention deficit hyperactivity disorder (ADHD). Currently, they require the written recommendation of a psychiatrist or paediatrician to start prescribing ADHD medications, which can takes months. ADHD drugs include Methylphenidate hydrochloride, that is also marketed as a ritalin, concerta, rubifen and teva. Currently there is a worldwide shortage of the drugs. Pharmac's website shows there's no stock for nine types of the drugs and low stock for two others. Half a dozen others have no supply issues. In a note added yesterday the drug buying agency said suppliers and wholesalers were also limiting the amount of stock going to pharmacies. Auckland dad Craig has a 10-year-old son who takes one of the ADHD medications that has supply problems. He told Checkpoint his family had been experiencing shortages of the medication for almost 18 months. "The last two times, directly, I've gone in to get it and there's actually none there. And the last time we had this was just last week and now there's effectively none 'till the end of July." He said they used the medication to help his son to concentrate at school, and now they were having to piece together whatever leftover drugs they could find to last them for the next month. "We've had so many changes of the different types of medicine we've got little bits and pieces left over that we've managed to cobble together for the next few weeks after the school holidays, but obviously that's not ideal." But these drugs weren't the first choice prescription for his son. "Different types of drugs last for extended periods, some of them which are better, and some are short-lasting, it's not really ideal... it just concerns me that it could get worse and it is a big deal for him." Craig said the type of medication his son was currently on had been hugely helpful, and when taking other types his mood and concentration could suffer. "This particular type that he's on now has been really helpful and it just, you know, keeps him more focused, right through the day. Other ones he'll drop off a bit quickly... that is a concern." Pharmac said rising demand and overseas manufacturing constraints had led to ongoing supply issues for ADHD medicines, and it was working with suppliers to secure more stock. Craig said while he was supportive of the recently announced changes around diagnosing and prescribing ADHD medication, he was now concerned the medication might be even harder to come by. "It took a while for this diagnosis to come through. It takes a lot of work, probably about a year or so, and a lot of people involved and a bit of expense for us at the time. "So I think it's a great thing that this might be able to be, you know, available for people quicker. "Everyone should get [the medication], and particularly, you know, use it wisely and as [how] it's supposed to be used. "But there's definitely a supply issue and all I could see from hearing [about the changes] was that it can only get worse." Pharmac's Director of Pharmaceuticals, Geraldine MacGibbon, said the recently announced changes making it easier for people to be diagnosed and prescribed stimulants for ADHD were delayed until February 2026 to give the health system more time to prepare, and improve supply of medicines. She said Pharmac was not expecting a significant short-term increase in the amount of people being diagnosed with ADHD or using ADHD stimulant medicines because of the changes. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
RNZ News
9 hours ago
- RNZ News
Kea almost ready to go home after hospitalisation for shot leg
A kea shot in the leg with a lead-based bullet in February is making a speeding recovery after being admitted to the Massey University Wildbase Hospital in Palmerston North. Photo: Supplied / Massey Universities Wildbase Hospital A kea that suffered a leg fracture after being shot has made an almost complete recovery, and vets have started plans for him head back home to the South Island. The injured bird was discovered with a severely infected left leg injury at Ligar Bay, near Tākaka in February after it was spotted walking with a limp. The bird was picked up by a Kea Conservation Trust worker. He was then flown to Wellington, before the Department of Conservation drove the bird to Massey University's Wildbase Hospital in Palmerston North which provides care to sick and injured native animals. The kea underwent several tests at the wildlife hospital - including radiographs and a CT scan - which showed an injury on the bird's leg caused by a lead-based bullet and left an open wound on his foot. Avian and wildlife veterinarian, Dr Megan Jolly, said the bird had likely got the injuries over the month prior to being found, and it quickly became apparent the bird's injuries stemmed from a gunshot wound. "There were fragments of the bullet still in the surrounding bone," Jolly said. She said vets also noticed an issue with his respiratory system, known as airsacculitis, which had caused breathing difficulties. Jolly said kea were known to develop stress-related health issues. She said throughout the kea's rehabilitation, it was a priority to keep him calm. "We do all the things we can to reduce his stress, we give him as much space as we can - he's had his own room in the hospital for months." "Being a kea, he likes to destroy stuff, so we give him lots of... native timbers and things to chew up and keep him as entertained as we can." Next steps in the rehabilitation process have included a move from Wildbase Hospital into the Central Energy Trust Wildbase Recovery - a transition aviary designed for native animals to regain strength after hospital treatment. "He'll be down there getting used to being outside, flying around again, and then we'll start to make a plan to get him back down South," Jolly said. Ash Murphy from the Department of Conservation (DOC) said while it's unknown if the kea was shot deliberately, there were previous incidents in Golden Bay where kea were shot and killed - and it took harming kea seriously. "Kea are protected under the Wildlife Act and the offence of hunting or killing kea carries a maximum penalty of up to two years' imprisonment or a fine of up to $100,000, or both," Murphy said. "Kea are a taonga species found in South Island alpine and forest areas. They are endangered in large part due to predators like stoats and feral cats. We need to do all we can to protect and live alongside them." She acknowledged the role of the Wildbase Hospital in the successful rehabilitation of the kea. Murphy encouraged anyone with information about the incident or other kea related incidents or injuries should call DOC's 24-hour hotline - 0800 DOC HOT. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
